| Ident. | Authors (with country if any) | Title |
|---|
| 000A70 (2007) |
Vesna Sossi [Canada] ; Raúl De La Fuente-Fernández [Espagne] ; Michael Schulzer [Canada] ; Andre R. Troiano [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] | Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study |
| 000A92 (2007) |
Philip Seeman [Canada] | Antiparkinson therapeutic potencies correlate with their affinities at dopamine D2High receptors |
| 000B47 (2006) |
Philip Seeman [Canada] ; Johannes Schwarz [Allemagne] ; Jiang-Fan Chen [États-Unis] ; Henry Szechtman [Canada] ; Melissa Perreault [Canada] ; G. Stanley Mcknight [États-Unis] ; John C. Roder [Canada] ; Rémi Quirion [Canada] ; Patricia Boksa [Canada] ; Lalit K. Srivastava [Canada] ; Kazuhiko Yanai [Japon] ; David Weinshenker [États-Unis] ; Tomiki Sumiyoshi [Japon] | Psychosis pathways converge via D2High dopamine receptors |
| 000B59 (2006) |
Kaveh M. Koochesfahani [Canada] ; Raúl De La Fuente-Fernández [Canada, Espagne] ; Vesna Sossi [Canada] ; Michael Schulzer [Canada] ; Lakshmi N. Yatham [Canada] ; Thomas J. Ruth [Canada] ; Stephan Blinder [Canada] ; A. Jon Stoessl [Canada] | Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: Positron emission tomographic studies |
| 000B77 (2006) |
Michel St-Hilaire [Canada] ; Emmanuelle Bourhis [Canada] ; Daniel Lévesque [Canada] ; Claude Rouillard [Canada] | Impaired behavioural and molecular adaptations to dopamine denervation and repeated L‐DOPA treatment in Nur77‐knockout mice |
| 000C67 (2005) |
S. Jourdain [Canada] ; M. Morissette [Canada] ; N. Morin [Canada] ; T. Di Paolo [Canada] | Oestrogens Prevent Loss of Dopamine Transporter (DAT) and Vesicular Monoamine Transporter (VMAT2) in Substantia Nigra of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Mice |
| 000C99 (2005) |
Ivar Mendez ; Rosario Sanchez-Pernaute [États-Unis] ; Oliver Cooper [États-Unis] ; Angel Vin Uela [États-Unis] ; Daniela Ferrari [États-Unis] ; Lars Bjo Rklund [États-Unis] ; Alain Dagher [Canada] ; Ole Isacson [États-Unis] | Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease |
| 000D29 (2004) |
Anthony E. Lang [Canada] ; José A. Obeso [Espagne] | Time to move beyond nigrostriatal dopamine deficiency in Parkinson's disease |
| 000D72 (2004) |
Rau L De La Fuente-Ferna Ndez [Canada] ; Vesna Sossi [Canada] ; Zhigao Huang [Canada] ; Sarah Furtado [Canada] ; Jian-Qiang Lu [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] | Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias |
| 000D77 (2004) |
Jackalina M. Van Kampen [Canada] ; Theo Hagg [Canada] ; Harold A. Robertson [Canada] | Induction of neurogenesis in the adult rat subventricular zone and neostriatum following dopamine D3 receptor stimulation |
| 000E01 (2004) |
Junchao Tong [Canada] ; Paul S. Fitzmaurice ; Lee Cyn Ang [Royaume-Uni] ; Yoshiaki Furukawa [Canada] ; Mark Guttman ; Stephen J. Kish | Brain dopamine‐stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy |
| 000E26 (2003) |
Antonio P. Strafella [Canada] ; Toma S Paus [Canada] ; Maria Fraraccio [Canada] ; Alain Dagher [Canada] | Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex |
| 000E78 (2003) |
Myreille D'Astous [Canada] ; Marc Morissette [Canada] ; Bastien Tanguay [Canada] ; Sophie Callier [Canada] ; Thérèse Di Paolo [Canada] | Dehydroepiandrosterone (DHEA) such as 17β‐estradiol prevents MPTP‐induced dopamine depletion in mice |
| 000F39 (2002) |
Yun J. Kim [Canada] ; Masanori Ichise [Canada] ; James R. Ballinger [Canada] ; Douglas Vines [Canada] ; Sean S. Erami [Canada] ; Tatsuro Tatschida [Canada] ; Anthony E. Lang [Canada] | Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP |
| 001015 (2001) |
P. K. Pal [Inde] ; Z. K. Wszolek [États-Unis] ; R. Uitti [États-Unis] ; K. Markopoulou [États-Unis] ; S. M. Calne [Canada] ; A. J. Stoessl [Canada] ; D. B. Calne [Canada] | Positron emission tomography of dopamine pathways in familial Parkinsonian syndromes |
| 001028 (2001) |
Stephen J. Crocker ; Nichola Wigle [Canada] ; Peter Liston [Canada] ; Charlie S. Thompson ; Chris J. Lee [Canada] ; Daigen Xu ; Sophie Roy [Canada] ; Donald W. Nicholson [Canada] ; David S. Park ; Alex Mackenzie [Canada] ; Robert G. Korneluk [Canada] ; George S. Robertson [Canada] | NAIP protects the nigrostriatal dopamine pathway in an intrastriatal 6‐OHDA rat model of Parkinson's disease |
| 001066 (2001) |
Frédéric Calon [Canada] ; Nadia Lavertu [Canada] ; Anne-Marie Lemieux [Canada] ; Marc Morissette [Canada] ; Martin Goulet [Canada] ; Richard Grondin [Canada] ; Pierre J. Blanchet [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Effect of MPTP‐induced denervation on basal ganglia GABAB receptors: Correlation with dopamine concentrations and dopamine transporter |
| 001081 (2001) |
Gerlinde A. S. Metz ; Tracy Farr ; Mark Ballermann ; Ian Q. Whishaw | Chronic levodopa therapy does not improve skilled reach accuracy or reach range on a pasta matrix reaching task in 6‐OHDA dopamine‐depleted (hemi‐Parkinson analogue) rats |
| 001082 (2001) |
Patricia Di Ciano [Royaume-Uni] ; Charles D. Blaha [Royaume-Uni] ; Anthony G. Phillips [Royaume-Uni, Canada] | Changes in dopamine efflux associated with extinction, CS-induced and d -amphetamine-induced reinstatement of drug-seeking behavior by rats |
| 001086 (2001) |
Raúl De La Fuente-Fernández [Canada] ; Jian-Qiang Lu [Canada] ; Vesna Sossi [Canada] ; Salma Jivan [Canada] ; Michael Schulzer [Canada] ; James E. Holden [États-Unis] ; Chong S. Lee [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] | Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover |
| 001161 (2000) |
Sophie Callier [Canada, France] ; Marc Morissette [Canada] ; Michelle Grbois [Canada] ; Thérèse Di Paolo [Canada] | Stereospecific prevention by 17β‐estradiol of MPTP‐induced dopamine depletion in mice |
